Upcoming Events
Search Result For "Preclinical".
- Event Type
- Event Category
- Event Country
- Event Date
Event Type
Categories
Country
City
Date
A high proportion of new drug candidates never reach market due to poor solubility, which limits their potential for absorption. As such, the solub...
Accelerating Biomarker-Driven Drugs into Clinical Trials Whilst Strategising Your CDx Development, IVDR Compliance and Commercialisation Path to Im...
There is a vast number of ADCs that never make it to the clinic let alone to market, and this is largely due to toxicological challenges providing ...
The challenges posed by the immune response is one of the biggest obstacles to developing safe, effective, and durable gene therapies. Over the las...
2023 is booming with novel psychiatric R AND D and the promise of precision medicine for neuropsychiatric patients. Pipelines are gaining momentum,...
Amongst the latest innovations in patient-derived iPSC models, 3D brain organoid models, advances in artificially driving neurodegeneration in vivo...
Despite a challenging 2022 for Gene Therapy developers targeting the CNS, the recent approvals of Skysona by bluebird bio and Upstaza by PTC Therap...
There's significant momentum in the clinical and preclinical pipeline for dry AMD, backed by record-breaking investments and acquisitions. This was...
2023 has seen advances in artificial intelligence, screening tools and progression into the clinic coupled with numerous strategic collaborations a...
Although no drug on the market has yet been discovered using AI, we're due to witness an instantaneous transformation soon as AI approaches an infl...
Following Merck announcing their goal to phase out animal use in their work, Astellas and MIMETAS expanding their partnership in immunotherapeutic ...
The 7th Antigen-Specific Immune Tolerance Drug Development Summit returns as the definitive, industry-dedicated forum bringing you the latest disco...
Loading More...
